Rheumatic immune-related adverse events with immune checkpoint inhibitors more severe than previously reported
For patients receiving immune checkpoint inhibitors (ICIs), rheumatic immune-related adverse events (rh-irAEs) are usually moderate or severe, with more than one-third leading to permanent ICI discontinuation, ...
22 Sep 21:00 · Medical Xpress